OR WAIT null SECS
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 8, 2022.
“Importantly, several different immunomodulation agents may be effective for increasing treatment response rates and seem well tolerated by patients with uncontrolled gout."
Results underline the importance of psychiatric evaluation and treatment in patients with fibromyalgia.
"Surveys of patients with SLE and other autoimmune and inflammatory rheumatic diseases have identified vaccine hesitancy in up to 50% of patients, which may be related to concerns about side effects, potential disease flares, or lack of data among patients with SLE.”
The findings of this study of anti-CD19 directed CAR T cell therapy offers new hope for the most severe and refractory cases.
The single-center, cross-sectional study assessed chair rise time, gait speed, and grip strength to determine the prevalence of sarcopenia.